Skip to main content

What the FDA labels say about taking them together

Erlotinib and rifabutin

Erlotinib's FDA label of June 10, 2024 names rifabutin in its drug interactions section; the rifabutin label PlainMeds reads does not name erlotinib. The erlotinib label: “Increase the erlotinib dosage if co-administration with CYP3A4 inducers is unavoidable.”

Check it at the source: the erlotinib FDA label on DailyMed (effective June 10, 2024, Alembic Pharmaceuticals Limited); the rifabutin FDA label on DailyMed (effective September 1, 2026, REMEDYREPACK INC.).

What does the erlotinib label say about rifabutin?

Erlotinib label, drug interactions

Increase the erlotinib dosage if co-administration with CYP3A4 inducers (e.g., carbamazepine, phenytoin, rifampin, rifabutin, rifapentine, phenobarbital and St. John's wort) is unavoidable [see Dosage and Administration (2.4)].

Source: FDA drug label (ERLOTINIB HYDROCHLORIDE), Alembic Pharmaceuticals Limited, effective June 10, 2024 (SPL set ab6f3cb3-34a8-4492-a5d7-fb6b055a2d6b), via openFDA; the full label on DailyMed

What does the rifabutin label say about erlotinib?

Rifabutin's label (effective September 1, 2026) does not name erlotinib in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Rifabutin), NDA050689 (Pfizer), as published by REMEDYREPACK INC., effective September 1, 2026 (SPL set 25a60937-cbbe-4a50-994f-2ce15203f589), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

10Erlotinib generic labelers
4Rifabutin generic labelers
ErlotinibRifabutin
Labeled forLung cancern/a
Boxed warningNoNo
Pharmacy cost (NADAC)n/a$8.14 per capsule 150 mg capsule
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?